Emerald updates its previously issued FY25 guidance range to $460M-$465M in revenue and $122.5M-$127.5M in Adjusted EBITDA, from its prior range of $450M-$460M in Revenue and $120M-$125M in Adjusted EBITDA, to reflect the acquisition of Generis.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EEX: